Abstract
An estimated 17.6 per 100,000 new cases of childhood cancer are diagnosed each year in the United States. The major subtypes of childhood cancer include leukemia, central nervous system tumors, lymphoma, neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, Wilms tumor, Germ cell tumors, and other rare tumors. Despite improvements in the diagnosis and treatment of these tumors over the last 30 years, subsets of children still have poor outcomes and many others have significant morbidity. Dysregulation of apoptotic pathways has been shown to contribute to tumor formation as well as resistance to therapy in both pediatric and adult malignancies. Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in diverse cancers and correlates with decreased patient survival. Here, we review the current literature on Survivin expression in pediatric cancer, its relationship to clinical outcome and potential therapeutic options to target this protein in pediatric cancer.
Keywords: Apoptosis, IAP, pediatric cancer, surviving, CNS tumor, caspase, Lymphoma, dysregulation, cytoplasm, Nucleus
Current Pediatric Reviews
Title: Inhibition of Apoptosis in Pediatric Cancer by Survivin
Volume: 7 Issue: 4
Author(s): Ayman Samkari and Rachel A. Altura
Affiliation:
Keywords: Apoptosis, IAP, pediatric cancer, surviving, CNS tumor, caspase, Lymphoma, dysregulation, cytoplasm, Nucleus
Abstract: An estimated 17.6 per 100,000 new cases of childhood cancer are diagnosed each year in the United States. The major subtypes of childhood cancer include leukemia, central nervous system tumors, lymphoma, neuroblastoma, rhabdomyosarcoma, osteosarcoma, Ewing sarcoma, Wilms tumor, Germ cell tumors, and other rare tumors. Despite improvements in the diagnosis and treatment of these tumors over the last 30 years, subsets of children still have poor outcomes and many others have significant morbidity. Dysregulation of apoptotic pathways has been shown to contribute to tumor formation as well as resistance to therapy in both pediatric and adult malignancies. Survivin, the smallest member of the inhibitor of apoptosis protein (IAP) family, is highly expressed in diverse cancers and correlates with decreased patient survival. Here, we review the current literature on Survivin expression in pediatric cancer, its relationship to clinical outcome and potential therapeutic options to target this protein in pediatric cancer.
Export Options
About this article
Cite this article as:
Samkari Ayman and A. Altura Rachel, Inhibition of Apoptosis in Pediatric Cancer by Survivin, Current Pediatric Reviews 2011; 7 (4) . https://dx.doi.org/10.2174/157339611796892283
DOI https://dx.doi.org/10.2174/157339611796892283 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Smart Phones As a Viable Data Collection Tool in Low-resource Settings: Case Study of Rwandan Community Health Workers
Neuroscience and Biomedical Engineering (Discontinued) Positive Social Interactions in a Lifespan Perspective with a Focus on Opioidergic and Oxytocinergic Systems: Implications for Neuroprotection
Current Neuropharmacology Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design New Biological Approaches in Asthma: DNA-Based Therapy
Current Medicinal Chemistry Helicobacter Pylori Infection, Immune Response and Vaccination
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Preventing and Treating Anthracycline-Related Cardiotoxicity in Survivors of Childhood Cancer
Current Cancer Therapy Reviews Therapeutic Application of Histone Deacetylase Inhibitors for Stroke
Central Nervous System Agents in Medicinal Chemistry Multi-element Analyses and Chemical-physical Investigations of Food Samples
Current Nutrition & Food Science MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs
Current Drug Targets The Role of Objective Numeracy and Fluid Intelligence in Sex-Related Protective Behaviors
Current HIV Research Damage-Associated Molecular Patterns – Emerging Targets for Biologic Therapy of Childhood Arthritides
Inflammation & Allergy - Drug Targets (Discontinued) HtrA Serine Proteases as Potential Therapeutic Targets in Cancer
Current Cancer Drug Targets Antibodies As Promising Novel Neuroprotective Agents in the Central Nervous System Injuries
Central Nervous System Agents in Medicinal Chemistry Calcium Metabolism & Hypercalcemia in Adults
Current Medicinal Chemistry Wnt Signaling in Liver Cancer
Current Drug Targets Bone Morphogenetic Protein-Smad Pathway as Drug Targets for Osteoporosis and Cancer Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism Indicators of Obesity and Cardio-metabolic Risks: Important Consideration in Adults and Children
Current Diabetes Reviews Review of Childhood Obesity (Balar Athidhoola Rogam) in Traditional Siddha Indian Medicine
Current Traditional Medicine Metabolic Syndrome and Aging: Calcium Signaling as Common Regulator
Current Diabetes Reviews